Ken Fisher Denali Therapeutics Inc. Transaction History
Fisher Asset Management, LLC
- $247 Billion
- Q4 2024
A detailed history of Ken Fisher (Fisher Asset Management, LLC) transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Fisher Asset Management, LLC holds 792,499 shares of DNLI stock, worth $11.7 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
792,499
Previous 547,331
44.79%
Holding current value
$11.7 Million
Previous $15.9 Million
1.3%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding DNLI
# of Institutions
238Shares Held
111MCall Options Held
80KPut Options Held
36.8K-
Black Rock Inc. New York, NY13.2MShares$195 Million0.01% of portfolio
-
Baillie Gifford & CO12.3MShares$182 Million0.2% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$178 Million0.0% of portfolio
-
Capital Research Global Investors Los Angeles, CA5.48MShares$81 Million0.02% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U05.36MShares$79.2 Million0.55% of portfolio
About Denali Therapeutics Inc.
- Ticker DNLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 134,174,000
- Market Cap $1.98B
- Description
- Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...